8-131955770-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015137.6(EFR3A):c.641G>T(p.Arg214Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000976 in 1,608,918 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R214H) has been classified as Likely benign.
Frequency
Consequence
NM_015137.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EFR3A | NM_015137.6 | c.641G>T | p.Arg214Leu | missense_variant, splice_region_variant | 7/23 | ENST00000254624.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EFR3A | ENST00000254624.10 | c.641G>T | p.Arg214Leu | missense_variant, splice_region_variant | 7/23 | 1 | NM_015137.6 | P3 | |
EFR3A | ENST00000519656.1 | c.533G>T | p.Arg178Leu | missense_variant, splice_region_variant | 7/23 | 1 | A1 | ||
EFR3A | ENST00000637848.1 | c.722G>T | p.Arg241Leu | missense_variant, splice_region_variant | 7/23 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000165 AC: 25AN: 151872Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000149 AC: 37AN: 248814Hom.: 0 AF XY: 0.000171 AC XY: 23AN XY: 134400
GnomAD4 exome AF: 0.0000906 AC: 132AN: 1457046Hom.: 1 Cov.: 30 AF XY: 0.000108 AC XY: 78AN XY: 724752
GnomAD4 genome AF: 0.000165 AC: 25AN: 151872Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74152
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | The c.641G>T (p.R214L) alteration is located in exon 7 (coding exon 7) of the EFR3A gene. This alteration results from a G to T substitution at nucleotide position 641, causing the arginine (R) at amino acid position 214 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at